JP6943859B2 - 駆虫性デプシペプチド化合物 - Google Patents

駆虫性デプシペプチド化合物 Download PDF

Info

Publication number
JP6943859B2
JP6943859B2 JP2018534122A JP2018534122A JP6943859B2 JP 6943859 B2 JP6943859 B2 JP 6943859B2 JP 2018534122 A JP2018534122 A JP 2018534122A JP 2018534122 A JP2018534122 A JP 2018534122A JP 6943859 B2 JP6943859 B2 JP 6943859B2
Authority
JP
Japan
Prior art keywords
independently
alkyl
substituted
alkoxy
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2018534122A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019504050A (ja
JP2019504050A5 (enExample
Inventor
イル ド ファロア ロアック ル
イル ド ファロア ロアック ル
チャールズ キュー メン
チャールズ キュー メン
グレゴリー パコフスキ
グレゴリー パコフスキ
ヒョン イク リー
ヒョン イク リー
アラン ロン
アラン ロン
Original Assignee
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド, ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド filed Critical ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド
Publication of JP2019504050A publication Critical patent/JP2019504050A/ja
Publication of JP2019504050A5 publication Critical patent/JP2019504050A5/ja
Application granted granted Critical
Publication of JP6943859B2 publication Critical patent/JP6943859B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2018534122A 2015-12-28 2016-12-14 駆虫性デプシペプチド化合物 Expired - Fee Related JP6943859B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562272040P 2015-12-28 2015-12-28
US62/272,040 2015-12-28
PCT/US2016/066497 WO2017116702A1 (en) 2015-12-28 2016-12-14 Anthelmintic depsipeptide compounds

Publications (3)

Publication Number Publication Date
JP2019504050A JP2019504050A (ja) 2019-02-14
JP2019504050A5 JP2019504050A5 (enExample) 2020-01-30
JP6943859B2 true JP6943859B2 (ja) 2021-10-06

Family

ID=57868331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018534122A Expired - Fee Related JP6943859B2 (ja) 2015-12-28 2016-12-14 駆虫性デプシペプチド化合物

Country Status (23)

Country Link
US (3) US10344056B2 (enExample)
EP (1) EP3397638B1 (enExample)
JP (1) JP6943859B2 (enExample)
KR (2) KR20220003663A (enExample)
CN (1) CN108699052B (enExample)
AR (1) AR107249A1 (enExample)
AU (2) AU2016380868B2 (enExample)
BR (1) BR112018013369A2 (enExample)
CA (1) CA3009867C (enExample)
CL (1) CL2018001744A1 (enExample)
CO (1) CO2018006527A2 (enExample)
HK (1) HK1255391A1 (enExample)
HU (1) HUE065907T2 (enExample)
IL (1) IL260262B2 (enExample)
MX (1) MX2018007948A (enExample)
MY (1) MY194716A (enExample)
NZ (1) NZ743913A (enExample)
PH (1) PH12018501367B1 (enExample)
RU (2) RU2020107484A (enExample)
SG (1) SG11201805368YA (enExample)
TW (1) TWI787165B (enExample)
UY (1) UY37050A (enExample)
WO (1) WO2017116702A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS62130B1 (sr) * 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
EP3397638B1 (en) 2015-12-28 2023-08-23 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
EP3579696B1 (en) 2017-02-08 2023-06-28 Boehringer Ingelheim Animal Health USA Inc. In vivo model for parasitic worm infection and methods for evaluating antiparasitic compounds, including compounds active against canine heartworm
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
PL3676265T3 (pl) 2017-11-07 2025-12-15 Elanco Animal Health Gmbh Sposób syntezy cyklicznych depsypeptydów
RU2747149C9 (ru) * 2017-11-29 2021-06-29 ЗОЕТИС СЕРВИСИЗ ЭлЭлСи Анти-эндопаразитарные депсипептиды
US11583545B2 (en) 2018-02-08 2023-02-21 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
US20220071183A1 (en) 2019-01-10 2022-03-10 Zoetis Services Llc Anthelmintic laboratory animal model for heartworm
KR20220002890A (ko) 2019-03-19 2022-01-07 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물
WO2021178834A1 (en) * 2020-03-06 2021-09-10 LifeMax Laboratories, Inc. Topical pharmaceutical formulations of a cyclic depsipeptide
BR112022024156A2 (pt) 2020-05-29 2023-02-14 Boehringer Ingelheim Animal Health Usa Inc Compostos heterocílicos antelmínticos
EP4262789A1 (en) 2020-12-21 2023-10-25 Boehringer Ingelheim Vetmedica GmbH Parasiticidal collar comprising isoxazoline compounds
US12258193B2 (en) 2022-02-17 2025-03-25 Boehringer Ingelheim Vetmedica Gmbh Method and system for providing a fluid product mailer
WO2025057117A1 (en) * 2023-09-15 2025-03-20 Animol Discovery, Inc. Antiparasitic cyclic depsipeptides
WO2025202940A2 (en) * 2024-03-27 2025-10-02 Animol Discovery, Inc. Antiparasitic cyclic depsipeptides

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
DK0634408T3 (da) 1992-03-17 2002-04-22 Fujisawa Pharmaceutical Co Depsipeptidderivater, fremstilling og anvendelse deraf
CN1073560C (zh) 1993-02-19 2001-10-24 明治制果株式会社 环缩酚酸肽pf1022衍生物
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
EP0718293B1 (en) 1993-09-06 2002-03-13 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
SE9303657D0 (sv) 1993-11-05 1993-11-05 Astra Ab Short-acting dihydropyridines
DE4400464A1 (de) 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4437198A1 (de) 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
DE19520275A1 (de) 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE69634961T2 (de) * 1995-09-22 2006-04-20 Bayer Ag Neue zyklische depsipeptid pf1022 derivate
DE69721055T2 (de) 1996-10-07 2004-02-19 Fujisawa Pharmaceutical Co., Ltd. Verfahren zur herstellung von depsipeptiden und zwischenprodukten davon
DE19713626A1 (de) 1997-04-02 1998-10-08 Bayer Ag Neue Thiodepsipeptide zur Bekämpfung von Endoparasiten und ein einfaches Verfahren zu ihrer Herstellung
US6355615B1 (en) 1997-06-04 2002-03-12 Bayer Aktiengesellschaft Desoxycyclodepsipeptides and their use for combatting endoparasites
DE19811559A1 (de) 1998-03-17 1999-09-23 Bayer Ag Cyclooctadepsipeptide
DE19828043A1 (de) 1998-06-24 1999-12-30 Bayer Ag Ektoparasitizide Mittel
DE19921887A1 (de) 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE19962147A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
DE19962145A1 (de) 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel/Depsipeptide
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
DE10104362A1 (de) 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
UY26592A1 (es) 2001-02-20 2001-09-28 Bayer Ag Agentes endoparasiticidas
US6893652B2 (en) * 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
US20040236191A1 (en) 2003-05-19 2004-11-25 Poliska Steven A. System and method for identifying and labeling livestock products, and managing data associated with those products
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
ES2351972T3 (es) 2004-02-27 2011-02-14 Ic Services Procedimiento y set para la identificación de animales.
DE102004055316A1 (de) 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
US20060202835A1 (en) 2005-02-25 2006-09-14 Osborne Industries, Inc. Dual frequency identification device
DE102008022520A1 (de) 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
DE102008030764A1 (de) 2008-06-28 2009-12-31 Bayer Animal Health Gmbh Kombination von Amidin-Derivaten mit cyclischen Depsipeptiden
DE102008031284A1 (de) 2008-07-02 2010-01-07 Bayer Schering Pharma Aktiengesellschaft Neue Bekämpfungsmöglichkeit der Giardiose
DE102008031283A1 (de) 2008-07-02 2010-01-07 Bayer Schering Pharma Aktiengesellschaft Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten
WO2010072323A1 (de) 2008-12-16 2010-07-01 Bayer Animal Health Gmbh Verfahren zur herstellung milchsäure- und phenylmilchsäurehaltiger optisch aktiver, cyclischer depsipeptide mit 24 ringatomen mit hilfe von pilzstämmen der art rosellinia sowie weiteren gattungen xylariaceen
KR101002530B1 (ko) 2009-02-18 2010-12-17 삼성에스디아이 주식회사 알에프아이디 통신 장치
WO2011069995A1 (en) 2009-12-11 2011-06-16 Bayer Animal Health Gmbh Novel 24-membered cyclooctadepsipeptides from fungal strains and their use as anthelmintics or endoparasiticides
WO2012028556A1 (en) 2010-08-31 2012-03-08 Bayer Animal Health Gmbh Macrocyclic lactones and their use and their combinations with other active substances
WO2012065031A2 (en) 2010-11-11 2012-05-18 Mlp Technology Inc. Animal data management
US9848290B2 (en) 2011-03-10 2017-12-19 Aruba Networks, Inc. Location based computerized system and method thereof
KR101978620B1 (ko) 2011-12-21 2019-08-28 바이엘 파마 악티엔게젤샤프트 무정형 에모뎁시드를 함유하는 제제
CA2876387A1 (en) 2012-06-13 2013-12-19 Meiji Seika Pharma Co., Ltd. Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the same
US20140306005A1 (en) 2013-04-14 2014-10-16 Forever Yours, Inc. Method for Data Transport and Recovery of Dependent Creatures
RS62130B1 (sr) 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
EP3397638B1 (en) 2015-12-28 2023-08-23 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos

Also Published As

Publication number Publication date
RU2018127195A (ru) 2020-01-30
EP3397638A1 (en) 2018-11-07
IL260262A (en) 2018-07-31
RU2018127195A3 (enExample) 2020-01-30
US20170233438A1 (en) 2017-08-17
NZ743913A (en) 2019-04-26
TWI787165B (zh) 2022-12-21
US20190248840A1 (en) 2019-08-15
CO2018006527A2 (es) 2018-07-10
MY194716A (en) 2022-12-15
TW201726670A (zh) 2017-08-01
AU2016380868B2 (en) 2019-11-28
JP2019504050A (ja) 2019-02-14
CA3009867A1 (en) 2017-07-06
AR107249A1 (es) 2018-04-11
KR20220003663A (ko) 2022-01-10
UY37050A (es) 2017-07-31
KR102427124B1 (ko) 2022-07-28
HUE065907T2 (hu) 2024-06-28
CN108699052A (zh) 2018-10-23
CN108699052B (zh) 2022-04-29
CL2018001744A1 (es) 2018-08-17
EP3397638B1 (en) 2023-08-23
SG11201805368YA (en) 2018-07-30
US12018048B2 (en) 2024-06-25
HK1255391A1 (zh) 2019-08-16
RU2020107484A (ru) 2020-03-19
AU2016380868A1 (en) 2018-07-19
MX2018007948A (es) 2018-08-01
KR20180100349A (ko) 2018-09-10
CA3009867C (en) 2022-05-31
IL260262B2 (en) 2023-06-01
AU2020200854A1 (en) 2020-02-27
US10344056B2 (en) 2019-07-09
US11230571B2 (en) 2022-01-25
RU2715556C2 (ru) 2020-03-02
BR112018013369A2 (pt) 2019-02-19
US20220098241A1 (en) 2022-03-31
WO2017116702A1 (en) 2017-07-06
AU2020200854B2 (en) 2021-08-05
PH12018501367B1 (en) 2022-10-21
PH12018501367A1 (en) 2019-02-27

Similar Documents

Publication Publication Date Title
TWI787165B (zh) 驅蟲酯肽化合物
JP7045191B2 (ja) 駆虫性デプシペプチド化合物
CN113825543B (zh) 驱虫的氮杂-苯并噻吩和氮杂-苯并呋喃化合物
CN112996788B (zh) 驱蠕虫的杂环化合物
JP2020504710A (ja) 駆虫性デプシペプチド化合物
RU2798093C2 (ru) Противогельминтные гетероциклические соединения
BR112021000257B1 (pt) Compostos heterocíclicos anti-helmínticos

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191216

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191216

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20200107

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20201126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210301

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210531

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210810

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210909

R150 Certificate of patent or registration of utility model

Ref document number: 6943859

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees